Evidence map›Paper›PMID 36330420›Full record

ArticleExtracellular vesicle2022

Computational analysis of serum-derived extracellular vesicle miRNAs in juvenile sheep model of single stage Fontan procedure.

Hyun-Ji Park, John M Kelly, Jessica R Hoffman, Felipe Takaesu, William Schwartzman, Anudari Ulziibayar, Takahiro Kitsuka, Eric Heuer, Asigul Yimit, Raphael Malbrue and 13 more

Open access · diamondAbstract read
In one paragraph

Article in Extracellular vesicle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  9. Engineering of Cell Derived-Nanovesicle as an Alternative to Exosome Therapy.Tissue engineering and regenerative medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 2 countries.

Hyun-Ji ParkWallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, USA.
John M KellyCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Jessica R HoffmanWallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, USA.
Felipe TakaesuWallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, USA.
William SchwartzmanThe Ohio State University College of Medicine, Columbus, OH, USA.
Anudari UlziibayarCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Takahiro KitsukaCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Eric HeuerCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Asigul YimitCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Raphael MalbrueThe Ohio State University College of Veterinary Medicine, Columbus, OH, USA.
Cole AndersonBiomedical Engineering Graduate Program, The Ohio State University, Columbus, OH, USA.
Adrienne MorrisonCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Aymen NaguibThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Christopher MckeeThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Andrew HarrisonThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Brian BoeThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Aimee ArmstrongThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Arash SalavitabarThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Andrew YatesThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Toshiharu ShinokaCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Sergio CarrilloThe Heart Center, Nationwide Children's Hospital, Columbus, OH, USA.
Christopher K BreuerCenter for Regenerative Medicine, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
Michael E DavisWallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, USA.
Nationwide Children's Hospital · USGeorgia Institute of Technology · USThe Ohio State University · US

Funding

Improving Tissue Engineered Vascular Graft Performance via Computational ModelingR01HL139796 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BREUER, CHRISTOPHER KANE, HUMPHREY, JAY D. · 2018 to 2025
$6.4M
Graduate Training in the Pharmacological StudiesT32GM008602 · NIGMS · EMORY UNIVERSITY · PI HALL, RANDY A. · 1996 to 2021
$5.1M
Predictive and systems modeling of exosome cargoR01HL145644 · NHLBI · EMORY UNIVERSITY · PI DAVIS, MICHAEL E · 2019 to 2022
$3.1M
Computational modeling of stem cells predicts clinical trial outcomes for hypoplastic left heart syndromeF31HL154725 · NHLBI · EMORY UNIVERSITY · PI HOFFMAN, JESSICA REGGAN · 2020 to 2021
$87k
NHLBI NIH HHS F31 HL154725NHLBI NIH HHS R01 HL139796NHLBI NIH HHS R01 HL145644NIGMS NIH HHS T32 GM008602
6 · The paper itself

Abstract

Patients with single ventricle heart defects requires a series of staged open-heart procedures, termed Fontan palliation. However, while lifesaving, these operations are associated with significant morbidity and early mortality. The attendant complications are thought to arise in response to the abnormal hemodynamics induced by Fontan palliation, although the pathophysiology underlying these physicochemical changes in cardiovascular and other organs remain unknown. Here, we investigated the microRNA (miRNA) content in serum and serum-derived extracellular vesicles (EVs) by sequencing small RNAs from a physiologically relevant sheep model of the Fontan operation. The differential expression analysis identified the enriched miRNA clusters in (1) serum vs. serum-derived EVs and (2) pre-Fontan EVs vs. post-Fontan EVs. Metascape analysis showed that the overexpressed subset of EV miRNAs by Fontan procedure target liver-specific cells, underscoring a potentially important pathway involved in the liver dysfunction that occurs as a consequence of Fontan palliation. We also found that post-Fontan EV miRNAs were associated with senescence and cell death, whereas pre-Fontan EV miRNAs were associated with stem cell maintenance and epithelial-to-mesenchymal transition. This study shows great potential to identify novel circulating EV biomarkers from Fontan sheep serum that may be used for the diagnosis, prognosis, and therapeutics for patients that have undergone Fontan palliation.

Indexed as

Extracellular vesicleFontan modelHemodynamicsMiRNARNA sequencing

Identifiers

PMID36330420
PMCPMC9623551
OpenAlexW4306818336

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.